🇺🇸 FDA
Pipeline program

FB102

FB102-701

Phase 1 small_molecule active

Quick answer

FB102 for Alopecia Areata is a Phase 1 program (small_molecule) at Forte Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Forte Biosciences
Indication
Alopecia Areata
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials